China National Pharmaceutical Group: In the first half of the year, operating income was 36.797 billion yuan, a year-on-year decrease of 2.62%.

Jin10 data reported on August 14th that China National Pharmaceutical Group (01099.HK) announced on the Hong Kong Stock Exchange that in the first half of 2025, China National Pharmaceutical achieved operating income of RMB 36.797 billion, a year-on-year decrease of 2.62%; the net profit attributable to shareholders of the listed company was RMB 666 million, a year-on-year decrease of 10.43%. The corresponding basic earnings per share decreased by 10.45% year-on-year, and the weighted average return on net assets decreased by 0.49 percentage points year-on-year.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)